Get started
Live feed
·
INSIDERFilingvia Quantisnow
Calidi Biotherapeutics Inc. logo

Director Leftwich Scott was granted 23,783 shares, increasing direct ownership by 5% to 493,686 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CLDICalidi Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLDI (Calidi Biotherapeutics Inc.) and more on Quantisnow.